Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.
Dealbreaker on MSN11h
J&J Bolsters Its Prospects in Brain Health With $14B Buyout of Intra-Cellular TherapiesJohnson & Johnson, already a big player in neuroscience drugs, is adding to its portfolio and pipeline with a deal to acquire ...
COVID-19 patients show a 37% higher risk of developing new gastrointestinal disorders compared to COVID ... SARS-CoV-2 virus ...
Health on MSN3d
What Causes a Gastrointestinal (GI) Bleed?Medically reviewed by Qin Rao, MD Gastrointestinal (GI) bleeding is a symptom of a disease, condition, or injury affecting ...
Discover how your blood type and genetic makeup influence your susceptibility to norovirus, plus expert tips to protect ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it has submitted the Clinical Study Report to the U.S. Food ...
Sacituzumab tirumotecan is under clinical development by Merck and currently in Phase II for Gastrointestinal Tract Cancer. According to GlobalData, Phase II drugs for Gastrointestinal Tract Cancer ...
BGBB-3227 is under clinical development by BeiGene and currently in Phase I for Gastrointestinal Tract Cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback